TAK

Takeda Pharmaceutical Co. Ltd.

Price

$17.85

return (12m)

p/e

-61.69

p/bv

1.16

DIVIDEND YIELD

3.68%

TAK price

Takeda Pharmaceutical

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment TAK

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals TAK

Valuation

P/E

-61.69

Sector -2.34

Industry -6.52

P/BV

1.16

Sector 2.17

Industry 1.78

P/Revenue (PSR)

1.82

Sector 2.00

Industry 3.10

EV/EBITDA

-26.96

Sector -23.69

Industry -28.17

EV/EBIT

-19.84

Sector -36.60

Industry -41.91

P/EBITDA

10.45

Sector -0.10

Industry -3.02

P/EBIT

195.97

Sector -2.08

Industry -5.99

P/Total Assets

0.55

Sector 1.18

Industry 1.22

P/Net Current Assets

-1.72

Sector -10.91

Industry -7.72

P/Working Capital

33.23

Sector 0.09

Industry 0.93

EPS

-0.28

Sector -0.93

Industry -1.40

BVPS

14.82

Sector 3.87

Industry 1.97

Efficiency

Gross Margin

65.14%

Sector 44.28%

Industry 46.71%

EBITDA Margin

-41.75%

Sector -291.45%

Industry -17,446,152.48%

EBIT Margin

-56.72%

Sector -195.44%

Industry -17,707,972.85%

Operating Margin

10.40%

Sector -25.72%

Industry -34.74%

Net Profit Margins

-2.95%

Sector -30.19%

Industry -38.14%

Asset Turnover

0.07

Sector 0.12

Industry 0.05

Profitability

ROE

-1.87%

Sector -34.71%

Industry -50.12%

ROA

-0.90%

Sector -28.76%

Industry -54.08%

ROIC

0.93%

Sector -441.27%

Industry -529.87%

Dividends

Dividend yield

3.68%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.09

Sector 1.87

Industry 2.30

Net Debt / EBITDA

-8.17

Sector -2.18

Industry 0.95

Net Debt / EBIT

-6.01

Sector -0.74

Industry -0.05

Net Debt / Equity

0.50

Sector -0.34

Industry -0.49

Gross Debt / Equity

0.59

Sector -0.64

Industry 0.03

Equity/Assets

0.48

Sector 0.43

Industry 0.46

Liabilities/Assets

0.52

Sector 0.46

Industry 0.41

Growth

5Y Revenue CAGR

-1.02%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals TAK

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
TAK Takeda Pharmaceutical Co. Ltd.	$17.85	34.53%	3.68%	-61.69	1.16	-1.87%	-2.95%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TAK Historical Dividends

current DY: 3.68%

5-year average DY: 5.31%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	09/30/2025	12/11/2025	0.32210000
Dividends	03/31/2025	07/07/2025	0.33900000
Dividends	09/30/2024	12/12/2024	0.33300000
Dividends	03/28/2024	07/08/2024	0.29220000
Dividends	09/29/2023	12/11/2023	0.31910000
Dividends	03/31/2023	07/10/2023	0.26900000
Dividends	09/30/2022	12/12/2022	0.30120000
Dividends	03/31/2022	07/11/2022	0.33010000
Dividends	09/30/2021	12/13/2021	0.39690000
Dividends	03/31/2021	07/12/2021	0.40660000
Dividends	09/30/2020	12/11/2020	0.43050000
Dividends	03/31/2020	07/06/2020	0.41900000
Dividends	09/30/2019	12/12/2019	0.41110000
Dividends	03/29/2019	07/10/2019	0.41720000
Dividends	09/28/2018	12/13/2018	0.39550000
Dividends	03/29/2018	07/09/2018	0.40640000
Dividends	09/29/2017	12/11/2017	0.39950000
Dividends	03/31/2017	07/10/2017	0.39890000
Dividends	09/30/2016	12/12/2016	0.39240000
Dividends	03/31/2016	07/11/2016	0.43700000
Dividends	09/30/2015	12/11/2015	0.36530000
Dividends	03/31/2015	07/09/2015	0.36530000
Dividends	09/29/2014	12/11/2014	0.37830000
Dividends	03/28/2014	07/10/2014	0.44370000
Dividends	09/27/2013	12/12/2013	0.43700000
Dividends	03/28/2013	07/08/2013	0.45710000
Dividends	09/27/2012	12/13/2012	0.54600000
Dividends	03/29/2012	07/09/2012	0.56380000
Dividends	09/29/2011	12/12/2011	0.57860000
Dividends	03/30/2011	07/07/2011	0.55580000
Dividends	09/29/2010	12/13/2010	0.53320000
Dividends	09/29/2009	12/15/2009	0.51780000
Dividends	03/30/2009	07/14/2009	0.48180000
Dividends	09/29/2008	12/16/2008	0.46810000

ABOUT Takeda Pharmaceutical

Takeda Pharmaceutical Co. Ltd.

Average Investor10 user rating

4.0 (0 people)

States of America

101 years

Founded: 1925

2010

Time since IPO - 16 years

47.495

Employees

Takeda Pharmaceutical Co. Ltd. (States of America) is listed on the NYSE and has a market capitalization of $54.11 billion, with shareholders equity totaling $46.83 billion.

The company employs approximately 47.495 people and operates in the Saúde sector, within the Principais Medicamentos industry.

Over the past 12 months, Takeda Pharmaceutical Co. Ltd. reported $29.73 billion in revenue, generating net income of $-877.25 million.

Key financial metrics include a P/E ratio of -61.69, a price-to-book (P/B) ratio of 1.16, and a trailing twelve-month dividend yield of 3.68%.

The company trades under the ticker TAK.

Market cap

$54.11 billion

Net worth

$46.83 billion

$46,827,090,000.00

Assets

$97.75 billion

$97,751,710,000.00

Total Shares Outstanding

3.16 billion

3,159,000,000

Average Daily Trading Volume

$3.28 million

$3,284,350.00

Sector

Saúde

Industry

Principais Medicamentos

TAK

revenue by Business Segment Takeda Pharmaceutical

TAK revenue and profits

Financial Results TAK

DRAG THE FRAME TO SEE MORE DATA

TAK cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56